Testing Information

Testing Status of Agents at NTP

Interferon AD (AIDS Initiative)

Print this pageFriendly URL

http://ntp.niehs.nih.gov/go/TS-M890009

CASRN: INTERFERONAD

Related: INTERFERON A

Formula: N/F

Known Uses:

EXPERIMENTAL AIDS THERAPY

Short-Term Toxicity

  • 4-WEEK (Subcutaneous Injection)  (C89003) Completed 
    • NTIS No. PB99-145807  (Peer Review 12/11/1996)
      Citation: Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/ a-Interferon A/D B6C3F1 Mice (Gavage Studies)
    • Mice: B6C3F1
    • Dose: 500, 5000, 50000, OR 500000 UNITS DAY

Long-Term Carcinogenicity

  • 2-YEAR (Subcutaneous Injection)  (C89003) Report Complete 
    • TR-469 (NTIS No. PB99-145807)  (Peer Review 12/11/1996)
      Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/ a-Interferon A/D B6C3F1 Mice (Gavage Studies)
    • Mice: B6C3F1
    • Dose: MICE ONLY: 500 OR 5000 UNITS 3X/WEEK; 50/SEX/GROUP